Localization of the sites and characterization of the mechanisms by which anti-light chain antibodies neutralize the actions of the botulinum holotoxin
Takahashi, Tsuyoshi, Joshi, Suresh G, Al-Saleem, Fetweh, Ancharski, Denise, Singh, Ajay, Nasser, Zidoon, Simpson, Lance L
Published in Vaccine (28.04.2009)
Published in Vaccine (28.04.2009)
Get full text
Journal Article
Evidence that botulinum toxin receptors on epithelial cells and neuronal cells are not identical: implications for development of a non-neurotropic vaccine
Elias, Md, Al-Saleem, Fetweh, Ancharski, Denise M, Singh, Ajay, Nasser, Zidoon, Olson, Rebecca M, Simpson, Lance L
Published in The Journal of pharmacology and experimental therapeutics (01.03.2011)
Published in The Journal of pharmacology and experimental therapeutics (01.03.2011)
Get full text
Journal Article
Identification of the factors that govern the ability of therapeutic antibodies to provide postchallenge protection against botulinum toxin: a model for assessing postchallenge efficacy of medical countermeasures against agents of bioterrorism and biological warfare
Al-Saleem, Fetweh H, Nasser, Zidoon, Olson, Rebecca M, Cao, Linsen, Simpson, Lance L
Published in The Journal of pharmacology and experimental therapeutics (01.08.2011)
Published in The Journal of pharmacology and experimental therapeutics (01.08.2011)
Get full text
Journal Article
Immunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge
Mustafa, Waleed, Al-Saleem, Fetweh H, Nasser, Zidoon, Olson, Rebecca M, Mattis, Jeffrey A, Simpson, Lance L, Schnell, Matthias J
Published in Vaccine (20.06.2011)
Published in Vaccine (20.06.2011)
Get full text
Journal Article